Acadia Pharmaceuticals Inc (NASDAQ: ACAD) reported a Q4 EPS loss of $(0.26), missing the consensus of $(0.24) and sales of $136.49 million, beating the consensus of $134.07 million. For FY23, the comp...
Tag: Pharmas
Pharma’s Strategy To Exploit A Depression-Era Antitrust Law Would Raise Drug Costs For Consumers
The prescription drug market is bewildering to many, and its complexity can make rational discussions about the causes of high drug prices exceedingly difficult. It also means that government official...